ISIS optronics GMVH
A device currently in development at ISIS optronics GMBH in Mannheim, Germany, could give dermatologists and cosmetic surgeons a new way to look at skin, and so help them tailor treatment to individual patients. The device might eventually prove useful for pre-screening pateints for skin diseases such as melanoma, a condition seen with increasing frequency around the glove.
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.